Sabir J. Rassiwalla

Private Equity Investor chez CR Group LP

Profil

Sabir Rassiwalla joined CRG in 2021 and serves as a Director.
Mr. Rassiwalla brings to CRG 20 years of investing, company building and transaction experience in the life science arena.
He is responsible for sourcing, diligence, execution, and portfolio management across healthcare with a particular focus on medical devices and surrounding ecosystem.
Prior to joining CRG, Mr. Rassiwalla spent 8 years at Abbott Ventures, the corporate venture arm of Abbott Laboratories, where he focused on strategic equity investments, acquisitions, and company formation efforts.
He was actively involved on portfolio company boards as well as in business strategy and operations across Abbott’s medical device franchises.
Earlier in his career, he was a member of Domain Associates, a leading healthcare venture capital fund, and a member of the transactions team at Onyx Pharmaceuticals.
Mr. Rassiwalla was also co-founder of a clinical research organization focused on emerging markets where he held business development and operational roles.
Mr. Rassiwalla received a Bachelor's degree in Bioengineering from the University of Pennsylvania and an M.B.A.
from INSEAD.

Postes actifs de Sabir J. Rassiwalla

Sociétés	Poste	Début
CR Group LP	Private Equity Investor	01/10/2021

Anciens postes connus de Sabir J. Rassiwalla

Sociétés	Poste	Fin
Abbott Ventures, Inc.	Private Equity Investor	30/09/2021
SIRO Clinpharm Pvt Ltd.	Fondateur	31/08/2010
Domain Associates LLC	Analyste en capital-investissement	15/12/2005

Formation de Sabir J. Rassiwalla

University of Pennsylvania	Undergraduate Degree
INSEAD	Masters Business Admin